Epidermal growth factor receptor inhibitors: a review of cutaneous adverse events and management.
about
Cutaneous adverse reactions specific to epidermal growth factor receptor inhibitorsAccelerated wound closure in vitro by fibroblasts from a subgroup of cleft lip/palate patients: role of transforming growth factor-αAcneiform Rash Induced by EGFR Inhibitors: Review of the Literature and New InsightsPatient considerations in metastatic colorectal cancer - role of panitumumab.A spectrum of cutaneous toxicities from erlotinib may be a robust clinical marker for non-small-cell lung therapy: a case report and literature reviewErlotinib-induced purpuric papulopustular eruption treated with pulsed azithromycin.ADAM17/EGFR axis promotes transglutaminase-dependent skin barrier formation through phosholipase C γ1 and protein kinase C pathways.Dermatologic Adverse Events Associated With Use of Adjuvant Lapatinib in Combination With Paclitaxel and Trastuzumab for HER2-Positive Breast Cancer: A Case Series Analysis.Exposure-Response Analysis of Necitumumab Efficacy in Squamous Non-Small Cell Lung Cancer Patients.Extreme Phenotype of Epidermal Growth Factor Receptor Inhibitor-induced Destructive Folliculitis.Osimertinib: A Novel Dermatologic Adverse Event Profile in Patients with Lung Cancer.The incidence and management of cutaneous adverse events of the epidermal growth factor receptor inhibitors.
P2860
Q26781472-BC183FCF-E222-449F-B32B-C7C1CE5F3CC0Q27332354-4D84377F-64CD-49C8-A963-76CD85F61975Q28081446-5945D6E4-FECA-46F7-A39B-E098D58C20DAQ33563293-7ACD22E0-69DE-49D3-A9BB-4ACD4F1D9941Q35541916-810625A3-0C56-4695-8201-F379378F6FBEQ36986839-CC789FCB-BA10-485A-80A3-471E58E428F6Q39683133-1EEB3923-11CF-4DD9-B880-CFBFB38048D8Q41018872-D0F6AD7A-3833-40ED-B23D-903DE6FFFDB6Q41526288-77469A5F-CDF8-42FA-B4F7-CF8CEA441D70Q41950779-BE4A44E2-E305-4D5A-B75C-99327206276EQ52591096-656CEC2C-9E94-4C5D-8122-DE83DF611928Q54982443-62F6F1E8-AAE0-4E27-AA6E-F573EF6B055A
P2860
Epidermal growth factor receptor inhibitors: a review of cutaneous adverse events and management.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epidermal growth factor recept ...... adverse events and management.
@en
Epidermal growth factor recept ...... adverse events and management.
@nl
type
label
Epidermal growth factor recept ...... adverse events and management.
@en
Epidermal growth factor recept ...... adverse events and management.
@nl
prefLabel
Epidermal growth factor recept ...... adverse events and management.
@en
Epidermal growth factor recept ...... adverse events and management.
@nl
P2093
P2860
P356
P1476
Epidermal growth factor recept ...... adverse events and management.
@en
P2093
K Chanprapaph
P Rattanakaemakorn
V Vachiramon
P2860
P304
P356
10.1155/2014/734249
P577
2014-03-02T00:00:00Z